S&P 500   4,209.73 (+0.10%)
DOW   32,971.05 (-0.37%)
QQQ   350.09 (+0.49%)
AAPL   177.54 (+1.20%)
MSFT   332.09 (-0.24%)
META   265.05 (+1.15%)
GOOGL   124.07 (-0.43%)
AMZN   121.71 (+1.33%)
TSLA   198.96 (+3.00%)
NVDA   403.02 (+3.48%)
NIO   7.39 (-4.03%)
BABA   78.60 (-2.93%)
AMD   126.34 (-0.54%)
T   15.65 (+0.97%)
F   12.67 (+4.80%)
MU   72.70 (-1.66%)
CGC   0.87 (-1.33%)
GE   102.14 (-0.58%)
DIS   87.53 (-0.86%)
AMC   4.55 (-1.94%)
PFE   37.10 (-1.33%)
PYPL   61.09 (+1.44%)
NFLX   393.28 (+3.80%)
S&P 500   4,209.73 (+0.10%)
DOW   32,971.05 (-0.37%)
QQQ   350.09 (+0.49%)
AAPL   177.54 (+1.20%)
MSFT   332.09 (-0.24%)
META   265.05 (+1.15%)
GOOGL   124.07 (-0.43%)
AMZN   121.71 (+1.33%)
TSLA   198.96 (+3.00%)
NVDA   403.02 (+3.48%)
NIO   7.39 (-4.03%)
BABA   78.60 (-2.93%)
AMD   126.34 (-0.54%)
T   15.65 (+0.97%)
F   12.67 (+4.80%)
MU   72.70 (-1.66%)
CGC   0.87 (-1.33%)
GE   102.14 (-0.58%)
DIS   87.53 (-0.86%)
AMC   4.55 (-1.94%)
PFE   37.10 (-1.33%)
PYPL   61.09 (+1.44%)
NFLX   393.28 (+3.80%)
S&P 500   4,209.73 (+0.10%)
DOW   32,971.05 (-0.37%)
QQQ   350.09 (+0.49%)
AAPL   177.54 (+1.20%)
MSFT   332.09 (-0.24%)
META   265.05 (+1.15%)
GOOGL   124.07 (-0.43%)
AMZN   121.71 (+1.33%)
TSLA   198.96 (+3.00%)
NVDA   403.02 (+3.48%)
NIO   7.39 (-4.03%)
BABA   78.60 (-2.93%)
AMD   126.34 (-0.54%)
T   15.65 (+0.97%)
F   12.67 (+4.80%)
MU   72.70 (-1.66%)
CGC   0.87 (-1.33%)
GE   102.14 (-0.58%)
DIS   87.53 (-0.86%)
AMC   4.55 (-1.94%)
PFE   37.10 (-1.33%)
PYPL   61.09 (+1.44%)
NFLX   393.28 (+3.80%)
S&P 500   4,209.73 (+0.10%)
DOW   32,971.05 (-0.37%)
QQQ   350.09 (+0.49%)
AAPL   177.54 (+1.20%)
MSFT   332.09 (-0.24%)
META   265.05 (+1.15%)
GOOGL   124.07 (-0.43%)
AMZN   121.71 (+1.33%)
TSLA   198.96 (+3.00%)
NVDA   403.02 (+3.48%)
NIO   7.39 (-4.03%)
BABA   78.60 (-2.93%)
AMD   126.34 (-0.54%)
T   15.65 (+0.97%)
F   12.67 (+4.80%)
MU   72.70 (-1.66%)
CGC   0.87 (-1.33%)
GE   102.14 (-0.58%)
DIS   87.53 (-0.86%)
AMC   4.55 (-1.94%)
PFE   37.10 (-1.33%)
PYPL   61.09 (+1.44%)
NFLX   393.28 (+3.80%)
NASDAQ:AMTX

Aemetis (AMTX) Stock Forecast, Price & News

$4.21
+0.04 (+0.96%)
(As of 12:52 PM ET)
Compare
Today's Range
$4.18
$4.61
50-Day Range
$1.73
$4.35
52-Week Range
$1.16
$11.50
Volume
538,166 shs
Average Volume
818,074 shs
Market Capitalization
$154.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.09

Aemetis MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
187.2% Upside
$12.09 Price Target
Short Interest
Healthy
17.93% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.04mentions of Aemetis in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.22) to ($0.19) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.09 out of 5 stars

Oils/Energy Sector

167th out of 249 stocks

Industrial Organic Chemicals Industry

10th out of 20 stocks


AMTX stock logo

About Aemetis (NASDAQ:AMTX) Stock

Aemetis, Inc. is a renewable fuels and biochemical company, which engages in the acquisition, development, and commercialization of technologies that replace traditional petroleum-based products. It operates through the North America and India geographical segments. The North America segment manages Keyes Plant in California, the cellulosic ethanol facility in Riverbank, the cluster of biogas digesters on dairies near Keyes, California, the Goodland Plant, Kansas and the research and development facility in Minnesota. The India segment refers to the Kakinada plant, administrative offices in Hyderabad, and holding companies in Nevada and Mauritius. Its products include glycerin, ethanol, food and feed, biodiesel, and edible oils. The company was founded by Eric Armstrong McAfee in 2006 and is headquartered in Cupertino, CA.

Receive AMTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aemetis and its competitors with MarketBeat's FREE daily newsletter.

AMTX Stock News Headlines

Aemetis, Inc. (NASDAQ:AMTX) Short Interest Down 13.8% in May
New "Mined in America" Lithium Opportunities?
The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.
New "Mined in America" Lithium Opportunities?
The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.
Aemetis, Inc. (NASDAQ:AMTX) Short Interest Update
Aemetis (NASDAQ:AMTX) Price Target Cut to $9.00
Where Aemetis Stands With Analysts
See More Headlines
Receive AMTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aemetis and its competitors with MarketBeat's FREE daily newsletter.

AMTX Company Calendar

Last Earnings
3/09/2023
Today
5/30/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Industrial organic chemicals
Sub-Industry
N/A
Current Symbol
NASDAQ:AMTX
Employees
158
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$12.09
High Stock Price Forecast
$27.00
Low Stock Price Forecast
$2.50
Forecasted Upside/Downside
+187.2%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
6 Analysts

Profitability

Net Income
$-107,760,000.00
Pretax Margin
-55.70%

Debt

Sales & Book Value

Annual Sales
$256.51 million
Book Value
($5.76) per share

Miscellaneous

Free Float
30,658,000
Market Cap
$154.46 million
Optionable
Not Optionable
Beta
1.18

Key Executives

  • Eric Armstrong McAfee
    Chairman & Chief Executive Officer
  • Todd A. WaltzTodd A. Waltz
    Chief Financial Officer, Secretary & Executive VP
  • Andrew B. FosterAndrew B. Foster
    Executive VP & President-Advanced Fuels Business
  • Sanjeev GuptaSanjeev Gupta
    Executive President-Aemetis International













AMTX Stock - Frequently Asked Questions

Should I buy or sell Aemetis stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aemetis in the last year. There are currently 1 sell rating, 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" AMTX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AMTX, but not buy additional shares or sell existing shares.
View AMTX analyst ratings
or view top-rated stocks.

What is Aemetis' stock price forecast for 2023?

6 equities research analysts have issued 1 year price objectives for Aemetis' stock. Their AMTX share price forecasts range from $2.50 to $27.00. On average, they predict the company's share price to reach $12.09 in the next twelve months. This suggests a possible upside of 187.2% from the stock's current price.
View analysts price targets for AMTX
or view top-rated stocks among Wall Street analysts.

How have AMTX shares performed in 2023?

Aemetis' stock was trading at $3.96 on January 1st, 2023. Since then, AMTX shares have increased by 6.3% and is now trading at $4.21.
View the best growth stocks for 2023 here
.

Are investors shorting Aemetis?

Aemetis saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 6,580,000 shares, a drop of 13.8% from the April 30th total of 7,630,000 shares. Based on an average daily volume of 971,100 shares, the days-to-cover ratio is currently 6.8 days.
View Aemetis' Short Interest
.

When is Aemetis' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our AMTX earnings forecast
.

How were Aemetis' earnings last quarter?

Aemetis, Inc. (NASDAQ:AMTX) posted its earnings results on Thursday, March, 9th. The specialty chemicals company reported ($0.63) earnings per share for the quarter, missing the consensus estimate of ($0.34) by $0.29. The specialty chemicals company had revenue of $66.73 million for the quarter, compared to analyst estimates of $74.82 million.

What ETFs hold Aemetis' stock?

ETFs with the largest weight of Aemetis (NASDAQ:AMTX) stock in their portfolio include Strategy Shares Halt Climate Change ETF (NZRO).

What other stocks do shareholders of Aemetis own?
What is Aemetis' stock symbol?

Aemetis trades on the NASDAQ under the ticker symbol "AMTX."

Who are Aemetis' major shareholders?

Aemetis' stock is owned by a number of institutional and retail investors. Top institutional investors include Grantham Mayo Van Otterloo & Co. LLC (5.82%), State Street Corp (1.82%), Geode Capital Management LLC (1.61%), Stifel Financial Corp (1.24%), CIBC Private Wealth Group LLC (0.69%) and Renaissance Technologies LLC (0.23%). Insiders that own company stock include Andrew B Foster, Andrew B Foster, Francis P Barton, Francis P Barton, John R Block, John R Block, Sanjeev Gupta, Timothy Alan Simon and Todd Waltz.
View institutional ownership trends
.

How do I buy shares of Aemetis?

Shares of AMTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aemetis' stock price today?

One share of AMTX stock can currently be purchased for approximately $4.21.

How much money does Aemetis make?

Aemetis (NASDAQ:AMTX) has a market capitalization of $154.46 million and generates $256.51 million in revenue each year. The specialty chemicals company earns $-107,760,000.00 in net income (profit) each year or ($3.38) on an earnings per share basis.

How many employees does Aemetis have?

The company employs 158 workers across the globe.

How can I contact Aemetis?

Aemetis' mailing address is 20400 STEVENS CREEK BLVD SUITE 700, CUPERTINO CA, 95014. The official website for the company is www.aemetis.com. The specialty chemicals company can be reached via phone at (408) 213-0940, via email at investors@aemetis.com, or via fax at 408-252-8044.

This page (NASDAQ:AMTX) was last updated on 5/30/2023 by MarketBeat.com Staff

My Account -